The low mood of kratom withdrawal has two layers, and most people are warned about only one.
The first is acute withdrawal dysphoria — the emotional flatness, irritability, and anxiety that accompany the first 7–14 days after stopping. Most people expect this, or at least recognize it as part of the process.
The second is the grey weeks: the post-acute anhedonia that follows acute withdrawal and can last weeks to months. This is the period when the physical symptoms have eased but the emotional baseline has not returned — when the ability to feel pleasure, motivation, and engagement has been hollowed out. For many people, this is the hardest phase of kratom recovery, and one of the most common relapse triggers.
TL;DR: Kratom's active alkaloid mitragynine produces dopamine release in the mesolimbic reward pathway, creating mood elevation during use. With regular use, the dopaminergic system adapts by downregulating its own baseline — the brain reduces its own sensitivity to dopamine. In withdrawal, this suppressed dopaminergic tone produces anhedonia (the inability to feel pleasure) and dysphoria that can be clinically indistinguishable from depression. For most people, this is a neurological recovery phase, not a permanent condition. The post-acute mood window typically improves progressively over weeks 4–12. If mood has not improved meaningfully by 4–6 weeks post-cessation, a clinical evaluation is appropriate — not because recovery failed, but because a prescriber can distinguish withdrawal-related mood changes from a pre-existing depressive condition that now warrants its own treatment. If you are having thoughts of not wanting to be here, the 988 Suicide and Crisis Lifeline (call or text 988) is available now.
How kratom affects mood — the dopaminergic mechanism
Kratom's primary active alkaloid, mitragynine, acts as a partial agonist at mu-opioid receptors distributed throughout the central nervous system — including within the mesolimbic dopamine pathway, the brain's primary reward and motivation circuit.
Opioid receptor activation in the mesolimbic pathway triggers dopamine release in the nucleus accumbens — the brain region central to motivation, pleasure, and reward processing. This is the same pathway activated by other drugs that produce pleasurable effects, and it is why kratom produces genuine mood elevation during use, particularly in the early stages.
The mood benefit during early kratom use is pharmacologically real. It is not willpower bypassed or a trick of expectation — the dopaminergic mechanism produces actual changes in subjective wellbeing. This is part of why the dependency develops: kratom delivers on what it promises, at least initially.
Why the mood effect fades during regular use
The brain's dopaminergic system, like other receptor systems, adapts to sustained activation. With chronic kratom use, the mesolimbic pathway responds to persistent opioid-driven dopamine release by downregulating: reducing the number of dopamine receptors, reducing receptor sensitivity, and reducing baseline dopamine production.
The result, described in Koob and Volkow's 2016 neurobiological framework on addiction (Nature Reviews Neuroscience), is a progressive decline in hedonic set point — the brain's baseline capacity for pleasure and reward. The doses that once produced reliable mood elevation no longer do. The functional emotional baseline — the mood state without kratom — becomes lower than it was before use began.
Many long-term kratom users describe this in retrospect as the shift from "kratom makes me feel good" to "kratom makes me feel normal" to "I can't function without it." The escalating dose is partly an attempt to restore the mood effect that neuroadaptation has removed.
The grey weeks — post-cessation dysphoria and anhedonia
When kratom stops, the mesolimbic dopamine system is operating in a downregulated state — with fewer receptors, lower baseline dopamine tone, and reduced capacity for reward processing. The external source of opioid-driven dopamine stimulation has been removed. The result is the post-acute withdrawal mood state:
Anhedonia — the clinical term for the inability to feel pleasure — is the defining feature. This is not sadness in the ordinary sense. It is the absence of reward signal: things that would normally feel satisfying, engaging, or pleasurable simply do not. Food tastes flat. Interests feel distant. Activities that used to provide relief or enjoyment do not reach. This is neurological, not motivational failure.
Dysphoria — a generalized state of unease, emotional flatness, and low mood — accompanies anhedonia in many people. Unlike the irritability and anxiety of acute withdrawal (which reflects the opioid receptor readjustment), post-acute dysphoria is a quieter, lower-level heaviness.
The timeline:
- Days 1–14 (acute withdrawal): Mood symptoms are mixed with physical withdrawal — anxiety, irritability, restlessness, and emotional dysregulation dominate. Mood is poor but animated.
- Weeks 2–4 (early post-acute): Physical withdrawal has largely resolved. Mood enters the grey phase — flatter, more sustained, lower energy. Anhedonia is most prominent here.
- Weeks 4–8 (mid post-acute): For most moderate users, this is the beginning of genuine improvement. The dopaminergic system is gradually recovering sensitivity. Small moments of pleasure and engagement begin returning.
- Weeks 8–12 (late post-acute): Most users report meaningful recovery in mood and motivation. Anhedonia recedes. Energy and interest in life reestablish.
- 3+ months: Full emotional baseline recovery for most users. Long-term heavy users, particularly those who used kratom for years, may have a longer arc.
This is post-acute withdrawal syndrome (PAWS) — the extended neurological recalibration period after the acute withdrawal window closes. It is well-documented in opioid recovery literature and is recognized as the period of highest relapse risk because the mood state itself is a strong trigger for returning to use.
Distinguishing withdrawal dysphoria from a depressive disorder
The clinical distinction matters because the treatment implications are different.
Substance-induced depressive disorder (DSM-5 category): depression-like symptoms caused by the pharmacological effects of a substance or its withdrawal. The defining feature is temporal relationship — symptoms emerge during or soon after substance withdrawal and typically resolve as the neurological system recovers. This is what most kratom users are experiencing in the grey weeks. It does not require antidepressant treatment in most cases; it requires time and supportive conditions.
Major depressive disorder (MDD): a primary depressive condition that exists independently of substance use. MDD may have been masked by kratom use (kratom was self-medicating an underlying condition), or may be genuinely unrelated to it. MDD warrants clinical evaluation and often responds to treatment.
How to think about the distinction:
- If depression predates kratom use, or if you have a first-degree family member with depression, the grey weeks may be uncovering a pre-existing condition rather than causing a new one.
- If mood is progressively improving over weeks 4–8, this points toward substance-induced dysphoria — the recovery arc is visible.
- If mood is not improving meaningfully by 4–6 weeks post-cessation, or if it is functionally impairing at that point, a clinical evaluation is appropriate.
You do not need to diagnose this yourself. A GP or psychiatrist can assess the timeline, rule out other causes (thyroid, hormonal — see our piece on kratom and testosterone for the hormonal dimension), and make a clinical determination.
What helps during the low-mood period of recovery
The most important thing to understand about the grey weeks is that the neurological recovery is happening whether or not you feel it — the dopaminergic system is restoring sensitivity, and supportive conditions accelerate that process.
Movement. Physical activity has the most consistent evidence base for improving post-acute mood in recovery. Exercise drives endorphin release, promotes neuroplasticity, and supports dopamine receptor upregulation — the biological process that directly reverses the anhedonia mechanism. The intensity matters less than the consistency. Walking counts. Start where you are.
Sleep. Post-acute mood recovery is dependent on sleep quality. The brain consolidates neurological recalibration during sleep; disrupted sleep prolongs the grey weeks. Sleep architecture is still recovering from kratom use; treating it as the top priority during this period is appropriate. See kratom and sleep for the full withdrawal insomnia guide.
Light exposure. Morning sunlight within 30–60 minutes of waking drives the cortisol awakening response and supports serotonin production. Even 10 minutes outside on a cloudy day has measurable effects on mood regulation. This is one of the simplest high-leverage interventions available in recovery.
Social connection. Isolation worsens post-acute anhedonia; even low-level social contact — a call, a shared meal, time with someone who knows what you are going through — provides neurological benefit. If the people in your life do not know about the quit, you do not need to explain fully — just not being alone matters.
Structure and routine. Anhedonia removes the internal reward signal that normally motivates daily activity. When reward is absent, external structure — a consistent schedule, commitments that create forward motion — functions as a substitute while the internal system recovers. Coach Aria's 12-week program is built in part for this: structured weekly sessions maintain forward motion when internal motivation is suppressed.
Professional support. If mood is functionally impairing — affecting work performance, relationships, or basic self-care — a conversation with a GP or therapist is appropriate at any point post-cessation. This is not giving up; it is using available support during a period of real neurological stress.
When low mood warrants clinical attention
If you are having thoughts of not wanting to be here, of not going on, or of harming yourself: reach out now. These thoughts are a known feature of the post-acute withdrawal period in opioid recovery. They are a symptom of the neurological state, not a permanent truth about your situation. The 988 Suicide and Crisis Lifeline is available 24/7 — call or text 988. You do not need to be in a crisis to call.
If mood is not improving by 4–6 weeks post-cessation or is functionally impairing your daily life at that point, see a GP or mental health clinician. A clinical evaluation at this stage is appropriate and productive — it clarifies whether you are experiencing substance-induced dysphoria on a longer timeline, or whether an underlying condition warrants its own treatment.
If this is not the first time you have felt this way — if depression has been a recurring pattern in your life, with or without kratom — that history is clinically relevant. Bring it to a clinician. Kratom cessation may be the moment when an underlying condition finally gets addressed.
For addiction medicine providers experienced in recovery who can assess mood in the context of your kratom history, findtreatment.gov lists providers including those who offer telehealth.
Coach Aria is a 12-week behavioral coaching program for kratom recovery. The program is designed for the full arc — including the grey weeks, when having a structured weekly framework and a private space to work through what is happening makes a concrete difference in sustained recovery. Private, no meetings, runs at your pace.